Share This Article:

Ubiquitin Reduces Expression of Intercellular Adhesion Molecules and Tumor Necrosis Factor-α in Lung Tissue of Experimental Acute Lung Injury

Abstract Full-Text HTML Download Download as PDF (Size:129KB) PP. 151-154
DOI: 10.4236/wjv.2012.23019    3,859 Downloads   5,829 Views   Citations

ABSTRACT

Background Intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) are two important cytokines in inflammatory response, which may induce rolling and adhesion of both leukocytes and lymphocytes, while modulating vascular permeability at the same time. These adhesion molecules usually serve as surrogate markers of activation and injury of vascular endothelial cells. Tumor necrosis factor-α (TNF-α) is a key factor to induce the expression and production of the above cell adhesion molecules. However, it remains to be elucidated whether exogenous ubiquitin exerts any effect on the cytokines in sepsis-induced ALI. Methods Sixty mice were devided randomly into five groups with twelve mice in each group, i.e. CLP group, SHAM group, UB1 group (10 mg/kg), UB2 group (5 mg/kg) and UB3 group(1 mg/kg). Mice of SHAM group underwent sham operation, and other four groups underwent CLP. Six hours after surgery, mice of three UB groups received ubiquitin by caudal vein injection while CLP and SHAM group received vehicle. Seven hours after surgery, blood and lungs of all mice were collected. ICAM-1, VCAM-1 and TNF-α level of 9% lung homogenate and serum TNF-α level were measured by ELISA. Results Pulmonary ICAM-1, VCAM-1 and TNF-α level of three UB groups were lower than CLP and SHAM group, and there were several comparisons with a statistically significant difference. Serum TNF-α level of three UB groups were slightly lower than CLP group, but far higher than SHAM group. Pulmonary ICAM-1 level, VCAM-1 level and serum TNF-α level of UB3 group were lower than UB1 and UB2 group, and there was a significant difference in VCAM-1 between UB3 and UB1 group. Pulmonary TNF-α level of UB3 group was slightly higher than UB1 and UB2 group.

Conflicts of Interest

The authors declare no conflicts of interest.

Cite this paper

Z. He and X. Juan, "Ubiquitin Reduces Expression of Intercellular Adhesion Molecules and Tumor Necrosis Factor-α in Lung Tissue of Experimental Acute Lung Injury," World Journal of Vaccines, Vol. 2 No. 3, 2012, pp. 151-154. doi: 10.4236/wjv.2012.23019.

References

[1] X. D. Guan and J. Xing, “Ubiquitin in Critical Care Medicine,” Zhonghua Yixue Zazhi, Vol. 87, No. 3, 2007, pp. 273-276.
[2] J. Xing, X. D. Guan and B. Ouyang, “Effects of Exogenous Ubiquitin on Lung Injury and Serum Nitrite/Nitrate in Mice at the Early Stage of Sepsis after Cecal Ligation and Perforation,” Chinese Journal of Respiratory and Critical Care Medicine, Vol. 8, No. 5, 2009, pp. 432-435.
[3] S. A. Earle, A. El-Haddad, M. B. Patel, et al., “Prolongation of Skin Graft Survival by Exogenous Ubiquitin,” Transplantation, Vol. 82, No. 11, 2006, pp. 1554-1546.
[4] X. P. Zhang, D. J. Wu and X. G. Jiang, “ICAM-1 and Acute Pancreatitis Complicated by Acute Lung Injury,” Journal of the Pancreas, Vol. 10, No. 1, 2009, pp. 8-14.
[5] R. A. Carter and I. P. Wicks, “Vascular Cell Adhesion Molecule 1(CD106): A Multifaceted Regulator of Joint Inflammation,” Arthritis & Rheumatism, Vol. 44, No. 5, 2001, pp. 985-994. doi:10.1002/1529-0131(200105)44:5<985::AID-ANR176>3.0.CO;2-P
[6] M. C. Subauste, D. C. Choi and D. Proud, “Transient Exposure of Human Bronchial Epithelial Cells to Cytokines Leads to Persistent Increased Expression of ICAM-1,” Inflammation, Vol. 25, No. 6, 2001, pp. 373-380. doi:10.1023/A:1012850630351
[7] C. Madjdpour, B. Oertli, U. Ziegler, et al., “Lipopolysaccharide Induces Functional ICAM-1 Expression in Rat Alveolar Epithelial Cells in Vitro,” American Journal of Physiology—Lung Cellular and Molecular, Vol. 278, No. 3, 2000, pp. L572-L579.
[8] M. Majetschak, S. M. Cohn, J. A. Nelson, et al., “Effects of Exogenous Ubiquitin in Lethal Endotoxemia,” Surgery, Vol. 135, No. 5, 2004, pp. 536-543. doi:10.1016/j.surg.2003.09.006
[9] J. R. Jacobson and J. G. Garcia, “Novel Therapies for Microvascular Permeability in Sepsis,” Current Drug Targets, Vol. 8, No. 4, 2007, pp. 509-514. doi:10.2174/138945007780362719

  
comments powered by Disqus

Copyright © 2019 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.